Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure

This publication has 43 references indexed in Scilit:

• Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol
  American Heart Journal, 1999
• Beta-adrenergic blocking agents
  Coronary Artery Disease, 1999
• 3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial
  The Lancet, 1998
• Rationale, Design, and Organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF)
  The American Journal of Cardiology, 1997
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• Evaluation of left ventricular mass: Comparison of ultrafast computed tomography, magnetic resonance imaging, and contrast left ventriculography
  American Heart Journal, 1993
• Effects of metoprolol on rest and exercise cardiac function and plasma catecholamines in chronic congestive heart failure secondary to ischemic or idiopathic cardiomyopathy
  The American Journal of Cardiology, 1990
• The Relationship Between Metoprolol Plasma Concentration and Beta₁‐Blockade in Healthy Subjects: A Study on Conventional Metoprolol and Metoprolol CR/ZOK Formulations
  The Journal of Clinical Pharmacology, 1990
• Evaluation of magnetic resonance imaging for determination of left ventricular ejection fraction and comparison with angiography
  The American Journal of Cardiology, 1988
• Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.
  Circulation, 1985